In Forbes’ “Love Only One” feature, which is returning after a long hiatus, we ask the biggest luminaries in different fields for their top picks in everything from stocks to gadgets. Here, we ask Nobel laureate James Watson, the co-discoverer of the structure of DNA and one of the first people to have his genome sequenced, to pick his favorite gene. From the May 21, 2012, issue of Forbes Magazine.
“One gene fascinates me: POMC, on chromosome 2, which is a recipe for a protein called Âpro-opiomelanocortin. In the body it gets broken up into different proteins, including melanotropin, which makes the skin darker when youâ
In March, comparing the price of a cancer drug on a per capita basis here and in India, I told drug companies how to charge $1.6 million per patient for a new drug — and get away with it. So long as companies make sure that all patients have access, I argued, it’s possible to convince governments and insurers to pay truly princely sums for medicines that really help patients.
Still, I thought that $1.6 million, was a sky high, off-the-charts, unbelievable amount. Â Surely, no medicine for sale today cost
- Digital Disruption - E2 Conference Boston
- The Language of UX: Beyond Buzzwords -
- Delve into technologies and business issues around mobile payments and wallets - Mobile Commerce World - Mobile Commerce World
- Learn how to best integrate mobile commerce with your current systems -- Mobile Commerce World - Mobile Commerce World
- Mobile Connect - E2 Conference Boston - E2 Conference Boston
- The Untapped Potential of Mobile Apps for Commercial Customers
- The Next Generation ESB: Why Integration is the Foundation for Better Business
- Secure Cloud: Taking Advantage of the Intelligent WAN
- Augment your data warehouse with big data solutions
- Real-Time Analytics: Big Data. Real Answers. Big Impact.
This Week's Issue
Free Print SubscriptionSubscribe
Current Government Issue
- The Government CIO 25: These influential and accomplished government IT leaders are finding ways to be cost efficient and still innovate.
- Rethink Video Surveillance: It's not just about networked cameras anymore. New technology provides analytics, automation, facial recognition, real-time alerts and situational-awareness capabilities.
- Read the Current Issue